Therefore, to establish a clear genotype-phenotype correlation for a patient with SMA and an intragenic mutation, two aspects of the effect of the intragenic mutation and SMN2 copy number should be considered. This evidence concerns the gene SMN2 and proximal spinal muscular atrophy.